Neil Averitt commentary: Where does antitrust fit in Trump’s drug pricing plan?
President Donald Trump has initiated a campaign to fight international price discrimination concerning pharmaceuticals by getting Americans the benefits of most-favored-nation status. The antitrust agencies are helping in this project, but...To view the full article, register now.
Already a subscriber? Click here to view full article